Alpha-synuclein quantitative seed amplification assay predicts conversion to dementia.

ABSTRACT:

Introduction

The alpha-synuclein seed amplification assay (SAA) has shown excellent performance in the detection of Lewy body pathology in cerebrospinal fluid (CSF). Lewy body pathology is prognostically relevant in patients at risk for dementia. Current assays only provide binary results, so there is a need to quantify the extent of pathology in living patients.

Methods

In addition to the "standard" SAA, we developed a quantitative SAA (qnSAA) and measured 432 CSF samples (216 baseline-follow-up pairs).

Results

qnSAA results correlated with cognitive performance. Seventy-five percent of participants with fast qnSAA kinetics converted to dementia in the observed interval. Overall, participants with fast qnSAA kinetics accounted for 27.3% of dementia converters in the

SUBMITTER: Brauer S 

PROVIDER: S-EPMC12828062 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature